A study published this month in Arthritis and Rheumatology concluded that nonsteroidal anti-inflammatory drugs (NSAID) may elevate the cardiovascular risk for patients with osteoarthritis. “Patients with OA were nearly 25% more likely than patients without OA to develop CVD (adjusted hazard ratio [HR], 1.23; 95% confidence interval [CI], 1.17 – 1.28). The researchers estimate that 41% of the increased CVD risk in those with OA was related to NSAID use,” according to a report by Medscape. Full story.
Categories
- AAHKS Amplified (154)
- AAHKS Business (217)
- AAHKS Leadership (198)
- Advocacy (318)
- AJRR (62)
- Annual Meeting (551)
- Arthroplasty Topics Podcast (128)
- Awards (45)
- Bundled Payments (18)
- Certification (6)
- CME (161)
- CMS (259)
- Reimbursement (52)
- Co-Branded Meetings (61)
- Committees and Task Forces (74)
- Corporate Partners (29)
- COVID-19 (42)
- Digital Health (13)
- Digital Health Podcast (7)
- Diversity (65)
- Education (237)
- eMentor (9)
- FARE (22)
- Federal Guidelines (108)
- Fellowships (98)
- FOCAL (72)
- Foundation (19)
- Grants (36)
- Guidelines (22)
- Humanitarian Award (20)
- Humanitarian Organizations (28)
- In Memoriam (17)
- In the News (301)
- Industry (96)
- International (79)
- LEARN (14)
- Legislation (66)
- Medicare (107)
- Membership (144)
- New Orthopaedic Headquarters (5)
- News Releases (13)
- Operation Walk (12)
- Opioids (9)
- Patient Education (71)
- Patient Outcomes (62)
- Performance Measures (28)
- Popular (122)
- Position Papers (11)
- Practice Management (76)
- Promotions (31)
- Publications (160)
- Research (371)
- FARE (5)
- Residents (90)
- SEO (7)
- Social Media (10)
- Specialty Day (17)
- Spring Meeting (104)
- Surveys (48)
- Technology (26)
- The Augment Podcast (82)
- The Cut Podcast (13)
- The Match (19)
- Uncategorized (47)
- Video (10)
- Webinars (161)
- Website (18)
- Wellness (7)
- Women in Arthroplasty (46)
- Women in Arthroplasty Podcast (3)
- Young Arthroplasty Group (148)
- Young Arthroplasty Group Podcast (92)
